These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Doppler sonographic enhancement of hepatic hemangiomas and hepatocellular carcinomas after perflenapent emulsion: preliminary study. Lopez-Ben R; Robbin ML; Weber TM; Smith JK; Needleman L; Berland LL J Ultrasound Med; 1999 Feb; 18(2):109-16. PubMed ID: 10206803 [TBL] [Abstract][Full Text] [Related]
3. Safety assessment of perflenapent emulsion for echocardiographic contrast enhancement in patients with congestive heart failure or chronic obstructive pulmonary disease. Kitzman DW; Wesley DJ Am Heart J; 2000 Jun; 139(6):1077-80. PubMed ID: 10827390 [TBL] [Abstract][Full Text] [Related]
4. Perflenapent emulsion: a US contrast agent for diagnostic radiology--multicenter, double-blind comparison with a placebo. EchoGen Contrast Ultrasound Study Group. Robbin ML; Eisenfeld AJ Radiology; 1998 Jun; 207(3):717-22. PubMed ID: 9609895 [TBL] [Abstract][Full Text] [Related]
5. Safety assessment of the use of perflenapent emulsion for contrast enhancement of echocardiography and diagnostic radiology ultrasound studies. Quay SC; Eisenfeld AJ Clin Cardiol; 1997 Oct; 20(10 Suppl 1):I19-26. PubMed ID: 9383598 [TBL] [Abstract][Full Text] [Related]
6. Effect of catheter diameter and injection rate of flush solution on renal contrast-enhanced ultrasonography with perfluorobutane in dogs. Hwang J; Kang K; Kang J; Nam J; Park S; Yoon J; Choi M Am J Vet Res; 2019 Sep; 80(9):825-831. PubMed ID: 31449446 [TBL] [Abstract][Full Text] [Related]
7. Quantitative contrast ultrasound analysis of renal perfusion in normal dogs. Waller KR; O'Brien RT; Zagzebski JA Vet Radiol Ultrasound; 2007; 48(4):373-7. PubMed ID: 17691639 [TBL] [Abstract][Full Text] [Related]
8. Renal, hepatic, and cardiac enhancement on Doppler and gray-scale sonograms obtained with EchoGen. Albrecht T; Cosgrove DO; Correas JM; Rallidis L; Nihoyanopoulos P; Patel N Acad Radiol; 1996 Aug; 3 Suppl 2():S198-200. PubMed ID: 8796561 [No Abstract] [Full Text] [Related]
9. The first phase I study of a novel ultrasound contrast agent (BR14): assessment of safety and efficacy in liver and kidneys. Basilico R; Blomley MJ; Cosgrove DO; Liull JB; Broillet A; Bauer A; Bonomo L Acad Radiol; 2002 Aug; 9 Suppl 2():S380-1. PubMed ID: 12188282 [No Abstract] [Full Text] [Related]
10. [Contrast echocardiography of the left heart by intravenous injection of perfluorochemical emulsion]. Matsuda M; Kuwako K; Sugishita Y; Ito I; Akatsuka T J Cardiogr; 1983 Dec; 13(4):1021-8. PubMed ID: 6678942 [TBL] [Abstract][Full Text] [Related]
11. Quantification of ultrasound contrast agent response: comparison of continuous wave Doppler and power Doppler to backscattered radiofrequency data. Lucidarme O; Correas JM; Bridal SL; Berger G Ultrasound Med Biol; 2001 Oct; 27(10):1379-86. PubMed ID: 11731051 [TBL] [Abstract][Full Text] [Related]
12. [Basic and clinical profile of perflubutane (Sonazoid powder for injection)]. Matsumura M; Sugihara H Nihon Yakurigaku Zasshi; 2007 Nov; 130(5):413-20. PubMed ID: 18000358 [No Abstract] [Full Text] [Related]
13. [The improvement of echocardiographic assessment of the left ventricle by the use of perflenapent and harmonic imaging]. Olszewski R; Marciniak W; Nowicki A; Gil M; Etienne J; Karłowicz P; Adamus J Pol Merkur Lekarski; 1998 Sep; 5(27):132-4. PubMed ID: 10101477 [TBL] [Abstract][Full Text] [Related]
14. Ultrasound contrast. Oral and i.v. agents amplify the image. Barr RG Diagn Imaging (San Franc); 1999 Mar; 21(3):56-61. PubMed ID: 10351114 [No Abstract] [Full Text] [Related]
15. Computed tomographic enhancement of the liver, liver abscesses, spleen, and major vessels with perfluorooctylbromide emulsion. Influence of dosage and injection velocity in an animal model. Adam G; Günther RW; Schiffer C; Görtz H; Prescher A; Scherer K Invest Radiol; 1992 Sep; 27(9):698-705. PubMed ID: 1399453 [TBL] [Abstract][Full Text] [Related]
16. Perfluorocarbon emulsions as intravenous delivery media for hyperpolarized xenon. Wolber J; Rowland IJ; Leach MO; Bifone A Magn Reson Med; 1999 Mar; 41(3):442-9. PubMed ID: 10204864 [TBL] [Abstract][Full Text] [Related]
17. Applying principles of pharmacoeconomic evaluation to perflenapent emulsion, a new echocardiographic contrast agent for use in cardiac function testing. Wellman G; Sherrin T Clin Ther; 1997; 19(4):837-46. PubMed ID: 9377626 [TBL] [Abstract][Full Text] [Related]
18. In vivo perfusion estimation using subharmonic contrast microbubble signals. Forsberg F; Liu JB; Shi WT; Ro R; Lipcan KJ; Deng X; Hall AL J Ultrasound Med; 2006 Jan; 25(1):15-21. PubMed ID: 16371551 [TBL] [Abstract][Full Text] [Related]
19. First Report of Perfluorobutane Microsphere-Enhanced Ultrasound in the Transplant Kidney. Siedlecki AM; Benson C; Frates M; Azzi J; Hoffman RJ; Milford E; Weins A; Chandraker A; Mc Donald N; Philip White J; Abdi R Transplantation; 2019 Oct; 103(10):e283-e284. PubMed ID: 31335773 [No Abstract] [Full Text] [Related]
20. Quantification of intravenous contrast-enhanced Doppler power spectrum in the rabbit carotid artery. Frush DP; Babcock DS; White KS; Barr LL Ultrasound Med Biol; 1995; 21(1):41-7. PubMed ID: 7754578 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]